## Abstract Prostate specific antigen (PSA) screening was introduced to detect prostate cancer at an early stage and to reduce prostate cancerβspecific mortality. Until results from clinical trials are available, the efficacy of PSA screening in reducing prostate cancer mortality can be estimated b
β¦ LIBER β¦
Recent trends in prostate cancer mortality show a continuous decrease in several countries
β Scribed by Wei, J.T.
- Book ID
- 121959761
- Publisher
- Elsevier Science
- Year
- 2008
- Weight
- 59 KB
- Volume
- 2008
- Category
- Article
- ISSN
- 0084-4071
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recent trends in prostate cancer mortali
β
Christine Bouchardy; Gerald Fioretta; Elisabetta Rapiti; Helena Maria Verkooijen
π
Article
π
2008
π
John Wiley and Sons
π
French
β 503 KB
International Trends in Prostate-Cancer
β
P.D. Baade; M.D. Coory; J.F. Aitken
π
Article
π
2004
π
Springer Netherlands
π
English
β 120 KB
International Trends in Prostate-Cancer
β
P. D. Baade, M. D. Coory and J. F. Aitken
π
Article
π
2004
π
Springer Netherlands
π
English
β 995 KB
Analysis of recent trends in prostate ca
β
Dennis, Leslie K.; Resnick, Martin I.
π
Article
π
2000
π
John Wiley and Sons
π
English
β 212 KB
π 2 views
## BACKGROUND. There is debate over whether the recent increases seen in prostate cancer are due to lead-time bias from screening, or identification of clinically insignificant lesions. METHODS. Population-based incidence rates for 1973-1996 were calculated, based on the Surveillance, Epidemiology,
Recent Trends in Prostate Cancer Inciden
β
Helen S. Evans; Henrik MΓΈller
π
Article
π
2003
π
Elsevier Science
π
English
β 233 KB
Prostate cancer incidence and mortality
β
F. Bray; J. Lortet-Tieulent; J. Ferlay; D. Forman; A. Auvinen
π
Article
π
2010
π
Elsevier Science
π
English
β 461 KB